Prof. Dmitri Pchejetski received an MSc (summa cum laude) from Lomonosov Moscow State University in 2000. He completed his PhD at Moscow State/Montreal Universities in 2003, and carried out post-doctoral research at Paul Sabatier University, Toulouse (2003–2005), and CNRS Institute of Structural Biology and Pharmacology, Toulouse (2005–2006). During this period, he also worked as a visiting scientist at McGill University, Canada. In 2006, Prof Pchejetski joined Imperial College London as a Research Fellow/Head of the Tumour Microenvironment and Chemotherapy group. Since April 2012, he has held a Senior Research Fellowship (and then a Research Professorship) at the Norwich Medical School, UEA. His current research interests include the molecular mechanisms of cancer pathogenesis, inflammatory response, cancer biomarkers, and novel targeted therapies.